Can HIV-specific immunity develop in HIV uninfected humans exposed to HIV whilst receiving
antiretroviral pre-exposure prophylaxis (PrEP)? Investigators will investigate this
possibility in commercial sex workers in Kampala who will be receiving Truvada PrEP for one
year.
Phase:
Phase 4
Details
Lead Sponsor:
MRC/UVRI and LSHTM Uganda Research Unit MRC/UVRI Uganda Research Unit on Aids
Treatments:
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir